كتاب Biomaterials Science - An Introduction to Materials in Medicine

أخوانى فى الله
أحضرت لكم كتاب
Biomaterials Science - An Introduction to Materials in Medicine
2nd Edition
Edited by
Buddy D. Ratner, Ph.D.
Professor, Bioengineering and Chemical Engineering
Director of University of Washington Engineered Biomaterials (UWEB), an
NSF Engineering Research Center
University of Washington, Seattle, WA USA
Allan S. Hoffman, ScD.
Professor of Bioengineering and Chemical Engineering
UWEB Investigator
University of Washington, Seattle, WA USA
Frederick J. Schoen, M.D., Ph.D.
Professor of Pathology and Health Sciences and Technology (HST)
Harvard Medical School
Executive Vice Chairman, Department of Pathology
Brigham and Women’s Hospital
Boston, MA USA
Jack E. Lemons, Ph.D.
Professor and Director of Biomaterials Laboratory Surgical Research
Departments of Prosthodontics and Biomaterials, Orthopaedic Surgery/Surgery and
Biomedical Engineering, Schools of Dentistry, Medicine and Engineering
University of Alabama at Birmingham, AL USA

و المحتوى كما يلي :

CONTENTS
Editors and Lead Contributors ix
Preface xi
Biomaterials Science: A Multidisciplinary
Endeavor 1
BUDDY D. RATNER, ALLAN S. HOFFMAN, FREDERICK J. SCHOEN,
AND JACK E. LEMONS
A History of Biomaterials 10
BUDDY D. RATNER
PART I
MATERIALS SCIENCE AND
ENGINEERING
CHAPTER 1 Properties of Materials
1.1 Introduction 23
JACK E. LEMONS
1.2 Bulk Properties of Materials 23
FRANCIS W. COOKE
1.3 Finite Element Analysis 32
IVAN VESELY AND EVELYN OWEN CAREW
1.4 Surface Properties and Surface
Characterization of Materials 40
BUDDY D. RATNER
1.5 Role of Water in Biomaterials 59
ERWIN A. VOGLER
CHAPTER 2 Classes of Materials Used in
Medicine
2.1 Introduction 67
ALLAN S. HOFFMAN
2.2 Polymers 67
STUART L. COOPER, SUSAN A. VISSER,
ROBERT W. HERGENROTHER, AND NINA M. K. LAMBA
2.3 Silicone Biomaterials: History
and Chemistry 80
ANDRÉ COLAS AND JIM CURTIS
2.4 Medical Fibers and Biotextiles 86
STEVEN WEINBERG AND MARTIN W. KING
2.5 Hydrogels 100
NICHOLAS A. PEPPAS
2.6 Applications of “Smart Polymers” as
Biomaterials 107
ALLAN S. HOFFMAN
2.7 Bioresorbable and Bioerodible Materials 115
JOACHIM KOHN, SASCHA ABRAMSON, AND ROBERT LANGER
2.8 Natural Materials 127
IOANNIS V. YANNAS
2.9 Metals 137
JOHN B. BRUNSKI
2.10 Ceramics, Glasses, and Glass-Ceramics 153
LARRY L. HENCH AND SERENA BEST
2.11 Pyrolytic Carbon for Long-Term Medical
Implants 170
ROBERT B. MORE, AXEL D. HAUBOLD, AND JACK C. BOKROS
2.12 Composites 181
CLAUDIO MIGLIARESI AND HAROLD ALEXANDER
2.13 Nonfouling Surfaces 197
BUDDY D. RATNER AND ALLAN S. HOFFMAN
vvi CONTENTS
2.14 Physicochemical Surface Modification
of Materials Used in Medicine 201
BUDDY D. RATNER AND ALLAN S. HOFFMAN
2.15 Textured and Porous Materials 218
JOHN A. JANSEN AND ANDREAS F. VON RECUM
2.16 Surface-Immobilized Biomolecules 225
ALLAN S. HOFFMAN AND JEFFREY A. HUBBELL
PART II
BIOLOGY, BIOCHEMISTRY,
AND MEDICINE
CHAPTER 3 Some Background Concepts
3.1 Background Concepts 237
BUDDY D. RATNER
3.2 The Role of Adsorbed Proteins in Tissue
Response to Biomaterials 237
THOMAS A. HORBETT
3.3 Cells and Cell Injury 246
RICHARD N. MITCHELL AND FREDERICK J. SCHOEN
3.4 Tissues, the Extracellular Matrix, and
Cell–Biomaterial Interactions 260
FREDERICK J. SCHOEN AND RICHARD N. MITCHELL
3.5 Mechanical Forces on Cells 282
LARRY V. MCINTIRE, SUZANNE G. ESKIN, AND ANDREW YEE
CHAPTER 4 Host Reactions to Biomaterials
and Their Evaluation
4.1 Introduction 293
FREDERICK J. SCHOEN
4.2 Inflammation, Wound Healing, and the
Foreign-Body Response 296
JAMES M. ANDERSON
4.3 Innate and Adaptive Immunity: The Immune
Response to Foreign Materials 304
RICHARD N. MITCHELL
4.4 The Complement System 318
RICHARD J. JOHNSON
4.5 Systemic Toxicity and Hypersensitivity 328
ARNE HENSTEN-PETTERSEN AND NILS JACOBSEN
4.6 Blood Coagulation and Blood–Materials
Interactions 332
STEPHEN R. HANSON
4.7 Tumorigenesis and Biomaterials 338
FREDERICK J. SCHOEN
4.8 Biofilms, Biomaterials, and Device-Related
Infections 345
BILL COSTERTON, GUY COOK, MARK SHIRTLIFF,
PAUL STOODLEY, AND MARK PASMORE
CHAPTER 5 Biological Testing of Biomaterials
5.1 Introduction to Testing Biomaterials 355
BUDDY D. RATNER
5.2 In Vitro Assessment of Tissue
Compatibility 356
SHARON J. NORTHUP
5.3 In Vivo Assessment of Tissue
Compatibility 360
JAMES M. ANDERSON AND FREDERICK J. SCHOEN
5.4 Evaluation of Blood-Materials Interactions 367
STEPHEN R. HANSON AND BUDDY D. RATNER
5.5 Large Animal Models in Cardiac and
Vascular Biomaterials Research
and Testing 379
RICHARD W. BIANCO, JOHN F. GREHAN, BRIAN C. GRUBBS,
JOHN P. MRACHEK, ERIK L. SCHROEDER,
CLARK W. SCHUMACHER, CHARLES A. SVENDSEN,
AND MATT LAHTI
5.6 Microscopy for Biomaterials Science 396
KIP D. HAUCH
CHAPTER 6 Degradation of Materials in the
Biological Environment
6.1 Introduction: Degradation of Materials in the
Biological Environment 411
BUDDY D. RATNER
6.2 Chemical and Biochemical Degradation of
Polymers 411
ARTHUR J. COURY
6.3 Degradative Effects of the Biological
Environment on Metals and Ceramics 430
DAVID F. WILLIAMS AND RACHEL L. WILLIAMS
6.4 Pathological Calcification of Biomaterials 439
FREDERICK J. SCHOEN AND ROBERT J. LEVYCONTENTS vii
CHAPTER 7 Application of Materials in Medicine,
Biology, and Artificial Organs
7.1 Introduction 455
JACK E. LEMONS AND FREDERICK J. SCHOEN
7.2 Nonthrombogenic Treatments and Strategies 456
MICHAEL V. SEFTON AND CYNTHIA H. GEMMELL
7.3 Cardiovascular Medical Devices 470
ROBERT F. PADERA, JR., AND FREDERICK J. SCHOEN
7.4 Implantable Cardiac Assist Devices 494
WILLIAM R. WAGNER, HARVEY S. BOROVETZ,
AND BARTLEY P. GRIFFITH
7.5 Artificial Red Blood Cell Substitutes 507
THOMAS MING SWI CHANG
7.6 Extracorporeal Artificial Organs 514
PAUL S. MALCHESKY
7.7 Orthopedic Applications 527
NADIM JAMES HALLAB, JOSHUA J. JACOBS,
AND J. LAWRENCE KATZ
7.8 Dental Implantation 556
A. NORMAN CRANIN AND JACK E. LEMONS
7.9 Adhesives and Sealants 573
DENNIS C. SMITH
7.10 Ophthalmological Applications 584
MIGUEL F. REFOJO
7.11 Intraocular Lens Implants: A Scientific
Perspective 592
ANIL S. PATEL
7.12 Burn Dressings and Skin Substitutes 603
JEFFREY R. MORGAN, ROBERT L. SHERIDAN,
RONALD G. TOMPKINS, MARTIN L. YARMUSH,
AND JOHN F. BURKE
7.13 Sutures 615
MARK S. ROBY AND JACK KENNEDY
7.14 Drug Delivery Systems 629
JORGE HELLER AND ALLAN S. HOFFMAN
7.15 Bioelectrodes 649
RAMAKRISHNA VENUGOPALAN AND RAY IDEKER
7.16 Cochlear Prostheses 658
FRANCIS A. SPELMAN
7.17 Biomedical Sensors and Biosensors 670
PAUL YAGER
7.18 Diagnostics and Biomaterials 685
PETER J. TARCHA AND THOMAS E. ROHR
7.19 Medical Applications of Silicones 698
JIM CURTIS AND ANDRÉ COLAS
CHAPTER 8 Tissue Engineering
8.1 Introduction 709
FREDERICK J. SCHOEN
8.2 Overview of Tissue Engineering 712
SIMON P. HOERSTRUP AND JOSEPH P. VACANTI
8.3 Immunoisolation 728
MICHAEL J. LYSAGHT AND DAVID REIN
8.4 Synthetic Bioresorbable Polymer Scaffolds 735
ANTONIOS G. MIKOS, LICHUN LU, JOHNNA S. TEMENOFF,
AND JOERG K. TESSMAR
PART III
PRACTICAL ASPECTS OF
BIOMATERIALS
CHAPTER 9 Implants, Devices, and Biomaterials:
Issues Unique to this Field
9.1 Introduction 753
FREDERICK J. SCHOEN
9.2 Sterilization of Implants and Devices 754
JOHN B. KOWALSKI AND ROBERT F. MORRISSEY
9.3 Implant and Device Failure 760
FREDERICK J. SCHOEN AND ALLAN S. HOFFMAN
9.4 Correlation, Surfaces and Biomaterials
Science 765
BUDDY D. RATNER
9.5 Implant Retrieval and Evaluation 771
JAMES M. ANDERSON, FREDERICK J. SCHOEN,
STANLEY A. BROWN, AND KATHARINE MERRITT
CHAPTER 10 New Products and Standards
10.1 Introduction 783
JACK E. LEMONS
10.2 Voluntary Consensus Standards 783
JACK E. LEMONS
10.3 Development and Regulation of Medical
Products Using Biomaterials 788
ELAINE DUNCANviii CONTENTS
10.4 Ethical Issues in the Development of
New Biomaterials 793
SUBRATA SAHA AND PAMELA SAHA
10.5 Legal Aspects of Biomaterials 797
JAY P. MAYESH AND MARY F. SCRANTON
CHAPTER 11 Perspectives and Possibilities in
Biomaterials Science 805
BUDDY D. RATNER, FREDERICK J. SCHOEN,
JACK E. LEMONS, AND ALLAN S. HOFFMAN
APPENDIX A Properties of Biological Fluids 813
STEVEN M. SLACK
APPENDIX B Properties of Soft Materials 819
CRISTINA L. MARTINS
APPENDIX C Chemical Compositions of Metals
Used for Implants 823
JOHN B. BRUNSKI
APPENDIX D The Biomaterials Literature 825
Index
INDEX
A
Absorbable matrix composites, 191
Absorbable synthetic fibers, 90
Absorbable synthetic sutures, 618–621
Absorption, multilayer polyelectrolyte,
211–212
Accommodative IOLs, 598–599
Acids; See Poly(amino acids);
pseudo-poly(amino acids), 119
Act, Biomaterials Access Assurance, 803
Activity, platelet coagulant, 334
Acute inflammation, 298–299
Adaptive immunity
innate and, 304–318
recognition and effector pathways in,
309–311
types of, 309
Adaptor/adhesive molecules, 263
Adhesion
bacterial, 347
platelet, 333
Adhesion proteins, effects of, 238–240
Adhesive biomaterials, composition and
characteristics of, 576–581
Adhesive molecules; See
Adaptor/adhesive molecules
Adhesives
hard-tissue, 579–580
soft-tissue, 576–579
surgical, 590
Adhesives and sealants, 572–583
background concepts, 573–576
characteristics of adhesive
biomaterials, 576–581
composition of adhesive biomaterials,
576–581
historical overview, 572–573
new research directions, 581–582
Adjustable power IOLs, 599
Adsorbed proteins in biomaterials,
importance of, 245
Adsorbed proteins in tissue response to
biomaterials, 237–246
adsorption behavior of proteins at
solid/liquid interfaces, 240–242
conformational and biological
changes, 242–245
effects of adhesion proteins on cellular
interactions, 238–240
importance of adsorbed proteins in
biomaterials, 245
molecular spreading events, 242–245
Adsorption behavior of proteins at
solid/liquid interfaces, 240–242
Adsorption; See also Preadsorption;
sorption
AFM (atomic force microscopy), 51–54,
221
Agar diffusion test, 358
Agents
immobilization of anti-platelet,
465–466
immobilization of fibrinolytic, 466
Aggregation, platelet, 333–334
Allergies, types of, 330–331
Allergy and biomaterials, 330
Allografts
from cadavers, 605–606
of cultured cells and collagen, 606
Alloys
cobalt-based, 144–148
cobalt-chromium, 536–537
new cobalt, 538–539
new tantalum, 537–538
new titanium, 538
new zirconium, 537–538
stainless steel, 536
titanium, 537
titanium-based, 148–151
Alloys, new, 537–539
new cobalt alloys, 538–539
new stainless steels, 539
new titanium alloys, 538
new zirconium and tantalum alloys,
537–538
surfaces and coatings, 539
Amino acids; See Poly(amino acids);
pseudo-poly(amino acids)
Amorphous matrix, 265
Analyses, finite element, 32–40
continuum equations, 35–36
examples from biomechanics, 37–40
finite element equations, 36–37
overview of finite element method,
33–35
surface analysis techniques, 42–56
Analyses, gene expression, 808
Animal experimentation, 794
Animal models and species
consideration, 381–390
canine, 381–386
sheep, 388–390
swine, 386–388
Animal models in cardiac research
testing, large, 379–396
Animal models in research testing, large
animal models and species
consideration, 381–390
responsible use of animals, 380–381
testing hierarchies, 390–392
Animal models in vascular research
testing, large, 379–396
Animal models, selection of for in vivo
tests, 364–365
Animal tumors, implants with human
and, 339–341
Animals, responsible use of, 380–381
Anti-platelet agents, immobilization of,
465–466
Antibody-mediated disease, pathogenesis
of, 313–314
antibody bound to cell surfaces or
fixed tissue antigens, 313–314
831832 INDEX
Antibody-mediated disease, pathogenesis
of (Continued)
IC (immune complex)-mediated injury,
314
IgE-mediated (immediate
hypersensitivity), 313
Apheresis, 516–524
centrifugal plasma separation,
519–520
cytapheresis, 523–524
defined, 518
membrane plasma filtration, 522–523
membrane plasma separation,
520–522
miscellaneous physicochemical
methods, 523
plasma exchange, 518–519
plasma treatment, 522
sorption plasma fractionation, 523
Apoptosis, 258–259
Apparatus, Golgi, 253–254
Apparel, drapes and protective, 97–98
Applications
bioelectrodes, 654–655
EO sterilization, 757–758
ophthalmological, 583–591
orthopedic, 526–555
of scaffolds, 737–740
in vivo, 97–99
Approaches
variational, 36
weighted residual, 36
Arms, linker, 692–694
Arrays, neuronal electrode, 808
Arrhythmias, cardiac, 483–485
Artery stents, coronary, 476–479
Arthroplasty
mold, 529–531
total hip replacement, 531–532
Arthroplasty, history of total hip,
529–532
femoral head prostheses, 531
long-stem prostheses, 531
mold arthroplasty, 529–531
short-stem prostheses, 531
total hip replacement arthroplasty,
531–532
Artifacts, 280
Artificial devices; See Bioartificial devices
Artificial endothelium, 588
Artificial epithelium, epikeratophakia
and, 587–588
Artificial heart, total implantable, 489
Artificial heart valves, 38–40, 798–799
Artificial organs, 709–748
extracorporeal, 514–526
immunoisolation, 728–734
overview of tissue engineering,
712–728
synthetic bioresorbable polymer
scaffolds, 735–747
Artificial prosthesis, 712
Artificial red blood cell substitutes,
507–514
hemoglobin, 507
modified hemoglobin, 507–511
perfluorochemicals, 511–512
Assay methods, 357–359
agar diffusion test, 358
direct contact test, 357–358
elution test, 358
interpretation of results, 358–359
Assays, new solid-phase materials for
ligand binding, 686–692
miscellaneous biosensor strategies,
691–692
molecularly imprinted surfaces,
690–691
particles, 686–689
self-assembled monolayers, 690
surface-enhanced spectroscopies, 691
Assessment, key considerations for BMI,
370–373
blood-factors affecting its properties,
370–371
blood interaction times, 373
how flow affects blood interactions,
371–372
properties of biomaterials and devices,
373
surfaces, 373
Assist
cardiac, 486–490
kidney, 514–518
lung substitutes and, 524
Assist devices
implantable cardiac, 494–503
ventricular, 487–489
Assurance Act, Biomaterials Access, 796
ASTM F67, 148
ASTM F75, 146
ASTM F90, 147
ASTM F136, 149
ASTM F562, 147–148
ASTM F799, 147
Atherosclerotic vascular disease, 476–483
Atomic structure, 25
Atopy, 331
Attachment, tissue, 154–155
Attack complex, membrane, 322
Auditory system, overview of, 658–659
Authorship, 795
B
Background concepts, 237–288
adsorbed proteins in tissue response to
biomaterials, 237–246
cells and cell injury, 246–260
mechanical forces on cells, 282–287
tissues and cell-biomaterial
interactions, 260–281
Bacterial adhesion to surfaces, 347
Behavior, elastic, 27
Bioactive glasses and glass-ceramics,
160–163
Bioactive molecules, delivery of, 732
Bioartificial devices, 525
Bioceramics
characteristics and processing of,
155–157
types of, 154–155
Biocompatibility, 809–810
and medical device performance,
765–766
of pyrolytic carbon, 177–179
standards, 786–787
Biocompatibility testing, ISO standard
for, 791–792
Biodegradable polymers, 79
Biodegradation, hydrolytic, 412–416
host-induced hydrolytic processes,
413–414
hydrolysis-preclinical and clinical
experience, 414–416
structures of hydrolyzable polymers,
412–413
Biodegradation, oxidative, 416–427
device- or environment-mediated
oxidation, 421–425
direct oxidation by host, 418–421
oxidation reaction mechanisms and
polymer structures, 416–418
oxidative degradation induced by
external environment, 425–427
Bioelectrodes, 649–656
applications, 654–655
electrode-electrolyte interface,
650–651
electrode materials, 653
equivalent circuit models, 651–652
factors influencing material selection,
652–653
Bioerodible materials, bioresorbable and,
115–127
applications of synthetic degradable
polymers as, 121–125
currently available degradable
polymers, 116–121
definitions and process of erosion
and/or degradation, 116
Bioerosion
factors influencing rate of, 124–125
process of, 123
Biofilm control, novel engineering
approaches to, 349
Biofilm formation on surfaces, 347–349INDEX 833
Biofilm microbiology, 346–347
bacterial adhesion to surfaces, 347
biofilm formation on surfaces,
347–348
natural control of biofilm formation
on surfaces, 348–349
novel engineering approaches to
biofilm control, 349
Biofilm-resistant biomaterials, 349–352
control of microbial colonization of
biomaterials, 351
delivery of biofilm control agents,
351–352
testing for antibacterial and antibiofilm
properties, 349–351
Biofilms, biomaterials and device-related
infections, 345–353
Biological effects of surface
microtexture, 222–224
Biological environment
corrosion and corrosion control in,
434–437
degradation of materials in, 411–453
influence of, 434
Biological fluids, properties of, 813–817
Biological properties assessed by in vivo
tests, specific, 366–368
Biological response to materials, water
and, 63–64
Biological stimuli, smart gels that
respond to, 112
Biological testing of biomaterials,
359–409
evaluation of BMIs (blood-materials
interactions), 371–383
large animal models in cardiac
research testing, 383–396
large animal models in vascular
research testing, 383–396
microscopy for biomaterials science,
396–409
in vitro assessment of tissue
compatibility, 360–364
Biology; See Microbiology; pathobiology
Biomaterial corrosion, orthopedic,
541–543
Biomaterial, silk as, 807–808
Biomaterial wear, orthopedic, 540–541
Biomaterials
adsorbed proteins in tissue response to,
235–244
allergy and, 334
biological testing of, 359–409
composition and characteristics of
adhesive, 576–581
and device-related infections, 349–357
and glucose sensing meet photonics,
805–806
importance of adsorbed proteins in,
245
inflammatory reaction to, 293–294
lack of pure and safe natural, 806
orthopedic, 528, 539–553
role of water in, 59–64
synthetic degradable polymers and,
121–125
tissue-derived, 317–318
tissue engineering using scaffold, 709
Biomaterials Access Assurance Act, 797
Biomaterials, biofilm-resistant, 349–352
control of microbial colonization of
biomaterials, 351
delivery of biofilm control agents,
351–352
testing for antibacterial and antibiofilm
properties, 349–351
Biomaterials components, kinetics and
nature of, 328–329
Biomaterials design, orthopedic, 524
Biomaterials, diagnostics and, 685–697
ligand immobilization on solid phases,
692–695
solid phase immunoreagents, 695–696
solid-phase materials for ligand
binding assays, 686–692
Biomaterials, ethical issues in
development
of new, 793–795
animal experimentation, 794
authorship, 795
clinical trials, 793–794
industrial support for research,
794–797
patents, 796–797
regulation, 795–796
Biomaterials, history of, 10–19
biomaterials before World War II,
10–12
contemporary era, 18–19
designed biomaterials, 17–18
modern biology and modern materials,
18–19
post World War II, 12–17
surgeon/physician hero, 12–17
Biomaterials, host reactions to,
293–350
biofilms, biomaterials and
device-related infections, 345–353
blood coagulation and blood-materials
interactions, 332–336
complement system, 318–328
immune response to foreign materials,
304–318
infection, 295–296
inflammation, wound healing and
foreign-body response, 296–304
inflammatory reaction to biomaterials,
293–294
innate and adaptive immunity,
304–318
systemic and remote effects, 294–295
systemic toxicity and hypersensitivity,
328–332
thromboembolic complications, 295
tumorigenesis, 295
tumorigenesis and biomaterials,
338–345
Biomaterials, legal aspects of, 797–804
artificial heart valves, 799–800
Biomaterials Access Assurance Act,
803
defensive manufacturing and
marketing, 804
intrauterine devices, 798–799
liability of design engineers, 803
pacemakers, 800
pedicle screws, 800–801
preemption, 802
science in courtrooms, 802–803
silicone breast implants, 801–802
Biomaterials, polymeric, 78–79
biodegradable polymers, 79
copolymers, 79
Biomaterials science, correlation,
surfaces and, 765–771
aspects of bioreaction to biomaterials,
767
biocompatibility and medical device
performance, 765–766
case for correlation, 767–769
correlation, 766–767
data, information, and statistics, 766
issues complicating simple
correlation, 769
multivariate correlation, 769–770
Biomaterials science, microscopy for,
396–409
configurations, 396–397
digital imaging, 404–406
fluorescence microscopy, 398–404
light microscopy, 397–398
magnification, resolution, and
contrast, 396
Biomaterials science - multidisciplinary
endeavor, 1–9
biomaterials and biomaterials
science, 1–2
biomaterials literature, 9
biomaterials societies, 9
characteristics of biomaterials
science, 4–6
examples of biomaterials applications,
2–4
subjects integral to biomaterials
science, 6–9834 INDEX
Biomaterials science, perspectives and
possibilities in, 805–829
biocompatibility, 809–810
biomaterials and glucose sensing meet
photonics, 805–806
circulating endothelial progenitor cells,
809
dental materials, 809
DNA technologies, 807
ethics, 810
gene expression analysis, 808
lack of pure and safe natural
biomaterials, 806
miscellaneous stem cells, 809
molecular imaging, 809
neuronal electrode arrays, 808
novel elastic and smart biopolymers,
808
self-assembled materials, 806
silk as biomaterial, 807–814
Biomaterials, tumorigenesis and,
338–345
implants with human and animal
tumors, 339–341
pathobiology of foreign body
tumorigenesis, 341–344
Biomechanics, examples from, 37–40
Biomedical sensors and biosensors, 670
Biomedical specialists, challenges to, 760
Biomolecules, surface-immobilized,
225–233
immobilization methods, 227–230
Biopolymers, novel elastic and smart,
813
Bioprosthetic heart valve calcification,
443–444
Bioresorbable and bioerodible materials,
115–127
applications of synthetic degradable
polymers, 121–125
currently available degradable
polymers, 116–121
definitions and process of erosion
and/or degradation, 116
Bioresorbable polymer scaffolds,
synthetic, 735–749
applications of scaffolds, 737–740
cell seeding and culture in 3D
scaffolds, 745–746
characterization of processed scaffolds,
745
scaffold design, 735–736
scaffold materials, 736–737
scaffold processing techniques,740–744
Biosensor strategies, miscellaneous,
691–692
Biosensors, 679–683
background, 680
sensing modalities, 680–683
Biosensors, biomedical sensors and, 670
biocompatibility, 673–674
biosensors, 679–683
classes of sensors, 674–679
consuming versus nonconsuming
sensors, 671–672
duration of use, 672–673
interaction of sensor with its
environment, 671
micrototal analytical systems, 682
physical versus chemical sensors, 670
sensors in modern medicine, 670
site of measurement, 672
Biosynthetic machinery, 253–254
Biotextiles, medical fibers and, 86–100
applications, 95–99
drapes and protective apparel, 95–99
medical fibers, 87–94
processing and finishing, 94
testing and evaluation, 94–95
topical and percutaneous applications,
97
in vivo applications, 97–99
Bladders, polymeric, 440–441
Bleeding, 505–506
Blood; See also Plasma/blood
Blood cell substitutes, artificial red,
507–514
hemoglobin, 507
modified hemoglobin, 507–511
perfluorochemicals, 511–512
Blood coagulation and blood-materials
interactions, 332–338
biofilm microbiology, 346–349
coagulation, 334
control mechanisms, 336–338
mechanisms of coagulation, 334–336
platelets, 332–334
Blood compatibility
defined, 367
measuring, 367–368
Blood contacting materials, 495–498
Blood interactions, how flow affects,
371–372
Blood-materials interactions, blood
coagulation and, 332–338
coagulation, 334
control mechanisms, 336–338
mechanisms of coagulation, 334–336
platelets, 332–334
Blood pumps
for chronic circulatory support,
502–505
polymeric bladders in, 440–441
Blood vessels, 720
BMI assessment, key considerations for,
370–373
blood-factors affecting its properties,
370–371
blood interaction times with materials
and devices, 373
how flow affects blood interactions,
371–372
properties of biomaterials and devices,
373
surfaces, 373
BMI evaluation, contemporary concepts
in, 377–378
BMIs (blood-materials interactions), 367
BMIs (blood-materials interactions),
evaluation of, 367–379
blood compatibility, 367
contemporary concepts in BMI
evaluation, 377–378
evaluation of BMIs, 374–377
key considerations for BMI
assessment, 370–373
measuring blood compatibility,
367–368
thrombogenicity, 368–370
in vitro tests of BMIs, 374–375
in vivo evaluation of devices, 376–377
in vivo tests of BMIs, 375–376
Bonding
covalent, 23–24
fiber, 741
ionic, 23
metallic, 24–25
weak, 25
Bone, 719
Braids, 95
Breast implants, 441–442
Breast implants, silicone, 801–802
Brittle fracture, 29
Burn dressings and skin substitutes,
602–614
advances in burn treatment, 602
permanent skin substitutes, 609–613
temporary skin substitutes, 605–609
wound coverage and healing, 602–605
wound coverage and skin substitutes,
604–605
C
Cadavers, allografts from, 605–606
Calcification, pathological, 439–451
assessment of biomaterials
calcification, 440–442
pathologic biomaterials and medical
device calcification, 440–442
pathophysiology, 444–448
prevention of calcification, 448–451
Calcified tissues, structure and properties
of, 528–529
Calcium phosphate
ceramics, 162–165
coatings, 165–166
Calcium phosphates, resorbable, 166
Canine, 381–386INDEX 835
Carbon
elemental, 169
pyrolytic, 38, 168–180
Carbon, biocompatibility of pyrolytic,
177–179
Carbon components, steps in fabrication
of pyrolytic, 173–177
Carbon fibers, 182
Carcinogenesis, 551–552
Cardiac arrhythmias, 483–485
Cardiac assist and replacement devices,
486–490
cardiopulmonary bypass, 486–487
complications of cardiac assist devices,
489–490
IABPs (intraaortic balloon pumps),
487
total implantable artificial heart, 489
ventricular assist devices, 487–489
Cardiac assist devices, complications of,
489–490
Cardiac assist devices, implantable,
494–507
blood contacting materials, 495–498
clinical need and applications,
494–495
complications and VAD
biocompatibility issues, 498–502
rotary blood pumps for chronic
circulatory support, 502–505
VADs (ventricular assist devices),
495–498
Cardiac pacemakers, 483–485
Cardiovascular devices, miscellaneous,
490–491
Cardiovascular implants, 777–778
Cardiovascular medical devices,
470–494
atherosclerotic vascular disease,
476–483
cardiac assist and replacement devices,
486–490
miscellaneous cardiovascular devices,
490–491
pacemakers and ICDs, 483–485
stents and grafts, 476–483
substitute heart valves, 472–476
Cartilage, 718–719
Cataracts, introduction to, 587–588
Cell-biomaterial interactions, 260–281
Cell housekeeping, normal, 246–248
Cell injection method, 713
Cell injury and regeneration, 255–256
Cell-matrix interactions, 265
Cell-mediated disease, pathogenesis of,
314–317
Cell regenerative capacity, 273–274
Cell responses to mechanical forces,
vascular, 282–285
Cell seeding and culture in 3D scaffolds,
745–746
miscellaneous culture conditions, 746
profusion culture, 746
rotary vessel culture, 746
spinner flask culture, 745–746
static culture, 745
Cell specialization and differentiation,
255
Cell/tissue-biomaterials interactions,
272–275
Cell transplantation, 737–738
Cells, 732
allografts of cultured, 606
circulating endothelial
progenitor, 809
combined with synthetic membranes,
608
endothelial, 462
identification, genotyping, and
functional assessment of, 280
miscellaneous stem, 809
red, 338
white, 338
Cells and cell injury, 246–260
apoptosis, 258–259
biosynthetic machinery, 253–254
causes of cell injury, 256–257
cell injury and regeneration, 255–256
cell specialization and differentiation,
255
cellular integrity and movement,
251–252
cytoskeleton, 251–252
energy generation, 254–255
Golgi apparatus, 253–254
lysosomes and proteasomes, 254
mitochondria, 254–255
necrosis, 258
normal cell housekeeping, 246–248
nucleus-central control, 252–253
pathogenesis of cell injury, 257
plasma membrane, 248–251
responses to cell injury, 257–258
rough and smooth ER (endoplasmic
reticulum), 253–254
waste disposal, 254
Cells and tissues, techniques for
analyses of, 276
artifacts, 280
electron microscopy, 279–280
identification and functional
assessment of cells, 280
light microscopy, 277–279
synthetic products in cells or tissue
sections, 280
three-dimensional interpretation, 280
Cells, mechanical forces on, 282–287
skeletal cell responses to mechanical
forces, 285–287
vascular cell responses to mechanical
forces, 282–285
Cells or tissue sections, synthetic
products in, 280
Cellular integrity and movement,
251–252
Cellular interactions, adhesion proteins
and, 238–240
Centrifugal plasma separation, 519–520
Ceramic degradation, 437–438
Ceramics, degradation effects on, 430
ceramic degradation, 437–438
corrosion and corrosion control,
434–437
influence of biological environment,
434
Ceramics, glasses and glass-ceramics,
153–168
bioactive glasses and glass-ceramics,
159–162
calcium phosphate ceramics, 162–165
calcium phosphate coatings, 165–166
characteristics and processing of
bioceramics, 155–157
clinical applications of HA
(hydroxyapatite), 166
nearly inert crystalline ceramics,
157–158
porous ceramics, 158–159
resorbable calcium phosphates, 166
types of bioceramics, 154–155
Ceramics; See also Bioceramics;
glass-ceramics, 25, 183, 534–535
calcium phosphate, 162–165
nearly inert crystalline, 157–158
porous, 158–159
Cervical spine, finite element model for
lower, 37–38
Chemical compositions of metals used
for implants, 822–823
Chemical degradation, mechanisms of,
123–124
Chemical sensors, 676–679
Chemical sensors, physical versus,
670
Chemically controlled delivery systems,
633–638
Chromium alloys; See Cobalt-chromium
alloys
Chronic inflammation, 299–304
Classical pathway, 319–320
Clinical applications of HA
(hydroxyapatite), 166
Clinical correlates, 325–327
Clinical trials, 793–794
of unapproved devices, 790–791836 INDEX
Closed-mold processes, 186
Closed-system method, 713
Coagulant activity, platelet, 334
Coagulation, 334
Coagulation, blood, 332–338
biofilm microbiology, 346–349
coagulation, 334
control mechanisms, 336–338
mechanisms of coagulation, 334–336
platelets, 332–334
Coagulation, mechanisms of, 334–336
Coatings
calcium phosphate, 165–166
conversion, 212
enteric, 640
new alloys and surface, 537–539
parylene, 212–213
Cobalt alloys, new, 538–539
Cobalt-based alloys, 145–149
Cobalt-chromium alloys, 536–537
Cochlear prostheses, 658–669
directions for future, 667
materials and electrode arrays,
661–666
overview of auditory system, 658–659
Collagen
allografts of cultured cells and, 606
biological consequences of, 132–134
chemical modification of, 132–134
graft copolymers of, 136
native structure of, 130–132
structure of native, 128–130
Collagen and elastin, 262–265
calcification of, 448
Colorants, 622–623
Compatibility; See also Biocompatibility
blood, 367
measuring blood, 367–368
in vitro assessment of tissue, 356–360
in vivo assessment of tissue, 360–367
Complement receptors, 324–325
Complement system, 318–328, 337–338
AP (alternative pathway), 320–322
classical pathway, 319–320
clinical correlates, 325–327
complement receptors, 324–325
control mechanisms, 322–324
future directions, 327
lectin pathway, 320
membrane attack complex, 322
Complexation hydrogels, 105
Complications, thromboembolic, 295
Components
kinetics and nature of biomaterials,
328–329
steps in fabrication of pyrolytic
carbon, 173–177
Composites, 180–196
absorbable matrix, 190
continuous fiber, 186–187
fracture fixation, 190–193
matrix systems, 183–184
mechanical and physical properties of,
186–190
particulate, 189–190
reinforcing systems, 182–183
short-fiber, 189
total joint replacement, 193
Composites, fabrication of, 184–186
fabrication of fiber-reinforced
composites, 184–186
fabrication of particle-reinforced
composites, 184
Composition, surface, 56–57
Compression molding, 742
Concepts, background, 237–288
adsorbed proteins in tissue response to
biomaterials, 237–246
cells and cell injury, 246–260
mechanical forces on cells, 282–287
tissues and cell-biomaterial
interactions, 260–281
Configurations, testing of
materials/design, 762–763
Consensus standards, voluntary,
783–788
biocompatibility standards, 786–787
standards, 783–784
users of standards, 784–785
writers of standards, 785–786
Constants, elastic, 28
Consuming versus nonconsuming
sensors, 671–672
Consumption, platelet, 56–57, 334
Contact-angle correlations, 57
Contact angle methods, 44–45
Contact lenses, 583–587
flexible perfluoropolyether lenses, 586
general properties, 583–584
rigid, 586–587
soft, 442
soft hydrogel, 584–586
Contact profilometry, 220
Continuous fiber composites, 186–187
Continuum equations, 35–36
Control, novel engineering approaches to
biofilm, 349
Conversion coatings, 212
Copolymers, 74, 79
Cornea, 715
Corneal implants; See also Intracorneal
implants, 587–589
Corneas, plastic, 589
Coronary artery stents, 476–479
Correlates, clinical, 325–327
Correlation, surfaces and biomaterials
science, 765–771
issues complicating simple correlation,
769
multivariate correlation, 769–770
Correlations
contact-angle, 57
issues complicating simple, 769
multivariate, 769–770
Corrosion
crevice, 436
fretting, 436
galvanic, 436–437
intergranular, 436
metallic, 432–434
orthopedic biomaterial, 542–544
pitting, 435
Corrosion cracking, stress, 436
Courtrooms, science in, 802–803
Covalent bonding, 23–24
Cracking, stress corrosion, 436
Creep and viscous flow, 30–31
Crevice corrosion, 436
Crystalline ceramics, nearly inert,
158–159
Crystallinity, 73
Culture
profusion, 746
rotary vessel, 746
spinner flask, 745–746
static, 745
Culture conditions, miscellaneous,
746
Culture in 3D scaffolds, cell seeding and
culture, 745–746
Cytapheresis, 523–524
Cytoskeleton, 251–252
D
DDS (drug delivery systems), 628–648
chemically controlled delivery systems,
633–638
diffusion-controlled delivery systems,
628–631
enteric coatings, 640
nucleic acid delivery systems, 640
particulate systems, 642–645
polymer therapeutic delivery systems,
642
regulated delivery systems, 641–642
in situ gelling delivery systems, 638
in situ precipitating delivery systems,
638
water penetration-controlled delivery
systems, 631–633
Defense mechanisms, adverse effects of,
329–330INDEX 837
Defensive manufacturing and marketing,
804
Deformation, plastic, 29–30
Degradable medical implants,
classification of, 121–123
Degradable polymers and biomaterials,
synthetic, 121–125
Degradable polymers, currently
available, 116–121
poly(amino acids), 119–121
pseudo-poly(amino acids), 119–121
Degradation
ceramic, 437–438
definitions and process of erosion
and/or, 116
mechanisms of chemical, 123–124
Degradation studied by SIMS,
poly(glycolic acid), 57
Degradative effects on metals and
ceramics, 430–439
ceramic degradation, 437–438
corrosion and corrosion control,
434–437
influence of biological environment,
438
Delivery systems
chemically controlled, 633–638
diffusion-controlled, 628–631
nucleic acid, 640
polymer therapeutic, 642
regulated, 641–642
in situ gelling precipitating, 638
in situ precipitating, 638
water penetration-controlled, 631–633
Dental implantation, 555–572
clinical environment, 567–569
currently used implant modalities,
559–566
general aspects of packaging and
preparation, 570
history, 555–559
tissue interfaces, 566–567
trends in research and development,
569–570
Dental implants, orthopedic and,
779–780
Dental materials, 809
Dentistry, application of materials in
medicine and, 455–707
adhesives and sealants, 572–583
dental implantation, 555–572
extracorporeal artificial organs,
514–526
strategies to lower thrombogenicity of
metals, 466
use of endothelial cells and RGD
peptides, 466
Deposition, LB (Langmuir-Blodgett),
208–209
Design
orthopedic biomaterials, 528
scaffold, 735–736
Design configurations, testing of
materials, 762–763
Design engineers, liability of, 803
Development of new biomaterials,
ethical issues in, 793–797
animal experimentation, 794
authorship, 795
clinical trials, 793–794
industrial support for research,
794–797
patents, 796–797
regulation, 795–796
Development, role of implant retrieval in
device, 776–777
Device development, role of implant
retrieval in, 776–777
Device failure, implant and, 760–765
biological testing of implants, 763
clinical handling and surgical
procedure, 764
design, 762
packaging, shipping, and storage, 764
patient/user, 764
raw materials, fabrication, and
sterilization, 763–764
testing of materials/design
configurations, 762–763
Devices
bioartificial, 525
changes to regulated medical, 792–793
clinical trials of unapproved, 790–791
immunologic toxicity of medical, 327
intrauterine, 798–799
miscellaneous cardiovascular, 490–491
sterilization of implants and, 754–760
ventricular assist, 487–489
in vivo evaluation of, 372–373
Devices, implantable cardiac assist,
494–507
blood contacting materials, 495–498
clinical need and applications,
494–495
complications and VAD
biocompatibility issues, 498–502
VADs (ventricular assist devices),
495–498
Diagnostics and biomaterials, 685–697
ligand immobilization on solid phases,
692–695
solid phase immunoreagents, 695–696
solid-phase materials for ligand
binding assays, 686–692
Dialysis, 514–518
Differential formulation, 35
Digital imaging, 404–406
Direct contact test, 357–358
Diseased tissues or organs, metabolic
products of, 712
Diseases
atherosclerotic vascular, 476–483
pathogenesis of cell-mediated,
314–317
valvular heart, 472–476
Diseases, pathogenesis of
antibody-mediated, 313–314
antibody bound to cell surfaces or
fixed tissue antigens, 313–314
IC (immune complex)-mediated injury,
314
IgE-mediated (immediate
hypersensitivity), 313
Dislocation, total hip, 37
Disposal, waste, 252
Distribution, mw (molecular weight),
509
DNA technologies, 807
Drapes and protective apparel, 96–97
Dressings
burn, 602–614
hydrocolloid, 608
Diffusion-controlled delivery systems,
628–631
E
ECM (extracellular matrix), 262–265
adaptor/adhesive molecules, 265
amorphous matrix, 265
collagens and elastin, 262–265
GAGs (glycosaminoglycans), 265
proteoglycans and hyaluronan, 265
Ectodermal derived tissue, 714–716
Elastic behavior, 27
Elastic constants, 28
Elasticity, 29
Elastin, 136
calcification of collagen and, 448
collagens and, 262–265
Elastomers, silicone, 82–84
cross-linking by addition, 83
cross-linking by condensation, 82–83
cross-linking with radicals, 82
elastomer filler, 83–84
Electrodes; See also Bioelectrodes
Electrode arrays, neuronal, 808
Electrode-electrolyte interface, 650–651
electrical double layer, 650–651
faradaic and nonfaradaic processes,
650
polarizable and nonpolarizable
electrodes, 650
Electron beam sterilization, 759
Electron microscopy, 279–280, 406–408
elemental analysis in SEM, 408
focused ion beam instruments, 408838 INDEX
Electron microscopy (Continued)
low-voltage imaging, 408
SEM (scanning electron microscopy),
404–408
variable pressure and ESEM, 408
Electron spectroscopy for chemical
analysis (ESCA), 45–46
Electrospinning, 88–89
Element analysis, finite, 32–40
continuum equations, 35–36
examples from biomechanics, 37–40
finite element equations, 36–37
overview of finite element method,
33–35
surface analysis techniques, 42–56
Element equations, finite, 36–37
Elemental carbon, 169
Elution test, 358
Embolism; See Thromboembolism
Encapsulation, concept of, 728
Encapsulation, fibrosis/fibrous, 302–304
Endoderm, 716–718
Endothelial cells and RGD peptides, 466
Endothelial progenitor cells, circulating,
808
Endothelium, artificial, 587
Energy generation, 252–253
Engineering, applications of tissue,
714–722
ectodermal derived tissue, 714–716
endoderm, 716–718
mesoderm, 718–722
Engineering, overview of tissue, 712–728
applications of tissue engineering,
714–722
future perspectives, 722
lost tissue or organ function, 712–728
replacing lost tissue or organ function,
713–714
Engineering, superstructure, 742
Engineers, liability of design, 803
Enteric coatings, 640
Environment
corrosion control in biological,
434–437
degradation of materials in biological,
411–453
influence of biological, 434
nature of plasma, 206
Environmental SEM (ESEM), 408
EO sterilization, 757–758
advantages and disadvantages, 758
applications, 758
EO residuals issues, 758
process and mechanism of action, 757
Epikeratophakia and artificial
epithelium, 587–588
Epithelium, epikeratophakia and
artificial, 587–588
Equations
continuum, 35–36
finite element, 36–37
ER (endoplasmic reticulum), rough and
smooth, 253–254
Erosion and/or degradation, definitions
and process of, 116
Erosion; See also Bioerosion
ESCA (electron spectroscopy for
chemical analysis), 45–46
ESEM (Environmental SEM), 408
Etching, reactive plasma and ion, 219
Ethical issues in development of new
biomaterials, 793–797
animal experimentation, 794
authorship, 795
clinical trials, 793–794
industrial support for research,
794–797
patents, 796–797
regulation, 795–796
Ethics, 810
Evaluation, contemporary concepts in
BMI, 377–378
Events, molecular spreading, 242–245
Examples from biomechanics, 37–40
Experimentation, animal, 794
Extracellular matrix
and cell-biomaterial interactions,
260–281
remodeling, 272
Extracorporeal artificial organs,
514–526
apheresis, 518–524
bioartificial devices, 525
development of extracorporeal
artificial organs, 525
kidney assist, 514–518
lung substitutes and assist, 524
Extrusion, 742–743
Eye, introduction to optics of, 591–592
F
Fabrication, effect on strength, 32
Fabrics, woven, 92–94
Failure, heart, 486–490
Failure, implant and device, 760–765
biological testing of implants, 763
clinical handling and surgical
procedure, 764
design, 762
packaging, shipping, and storage, 764
patient/user, 764
raw materials, fabrication, and
sterilization, 763–764
testing of materials/design
configurations, 762–763
Fatigue, 31
Femoral head prostheses, 531
Fiber bonding, 741
Fiber selection, polymer and, 89–90
Fibers
absorbable synthetic, 90
carbon, 182
hybrid bicomponent, 91–92
modified natural, 90–91
polymer, 182–183
Fibers, medical, 86–100, 87–94
absorbable synthetic fibers, 90
hybrid bicomponent fibers, 91–92
modified natural fibers, 90–91
synthetic fibers, 87–90
Fibers, synthetic, 87–90
electrospinning, 88–89
melt spinning, 87–88
polymer and fiber selection, 89–90
wet spinning, 88
Fibrinolysis, 333
Fibrinolytic agents, immobilization of,
466
Fibrosis/fibrous encapsulation, 202–304
Filament-winding process, 186
Filtration, membrane plasma, 522–523
Finite element analysis, 32–40
Finite element equations, 36–37
Finite element method, overview of,
33–35
Fixation, fracture, 190–193
Flask culture, spinner, 745–746
Flow, creep and viscous, 30–31
Fluids, properties of biological, 813–817
Fluorescence microscopy, 398–404
Foreign-body reaction, 301–302
Foreign-body response, 296–304
Foreign body tumorigenesis,
pathobiology of, 341–344
Foreign materials, immune response to,
304–318
Formation; See also Deformation
Formation on surfaces, natural control
of biofilm, 348–349
Formulations
differential, 35
variational, 35–36
Fractionation, sorption plasma, 519
Fracture, brittle, 29
Fracture fixation, 190–193
Freeze-drying, 742
Fretting corrosion, 432
Functions
IOLs with variations of optical,
597–599
properties of interpolating, 36–37
replacing lost tissue or organ, 713–714
Functions, therapeutic approaches for
lost tissue or organ, 712
artificial prosthesis, 712INDEX 839
metabolic products of diseased tissues
or organs, 712
surgical reconstruction, 712
transplantation, 712
G
GAGs (glycosaminoglycans), 134–136,
263
Galvanic corrosion, 436–437
Gas foaming (GF), 743
Gas processes, miscellaneous, 205–206
Gene expression analysis, 808
Generation, energy, 254–255
Genotoxicity, 362–363
GF (gas foaming), 744
Glass-ceramics, bioactive glasses and,
159–162
Glass-ceramics, ceramics, glasses and,
153–168
bioactive glasses and glass-ceramics,
159–162
calcium phosphate ceramics, 162–165
calcium phosphate coatings, 165–166
characteristics and processing of
bioceramics, 155–157
clinical applications of HA
(hydroxyapatite), 166
nearly inert crystalline ceramics,
157–158
porous ceramics, 158–159
resorbable calcium phosphates, 166
types of bioceramics, 154–155
Glasses, 183
bioactive, 159–162
inorganic, 25–26
Glasses and glass-ceramics, ceramics,
153–168
bioactive glasses and glass-ceramics,
159–162
calcium phosphate ceramics, 162–165
calcium phosphate coatings, 165–166
characteristics and processing of
bioceramics, 155–157
clinical applications of HA
(hydroxyapatite), 166
nearly inert crystalline ceramics,
157–158
porous ceramics, 158–159
resorbable calcium phosphates, 166
types of bioceramics, 154–155
Glaucoma, implants for, 589–590
Glucose sensing meet photonics,
biomaterials and, 805–806
Glycosaminoglycans (GAGs), 134–136,
265
Glycosaminoglycans, graft copolymers
of, 136
Golgi apparatus, 253–254
Graft copolymers of collagen, 136
Graft copolymers of glycosaminoglycans,
136
Grafts; See also Allografts; xenografts
peripheral stents and stent, 479
stents and, 476–483
vascular, 479–483
Granulation tissue, 300–301
Groups, polymers containing
hydrolyzable pendant, 416
H
HA (hydroxyapatite), clinical
applications of, 166
Hard-tissue adhesives, 579–580
Healing, wound, 296–304
Healing, wound coverage and, 602–604
Heart disease, valvular, 472–476
Heart failure, 486–490
Heart, total implantable artificial, 489
Heart valve calcification,
pathophysiology of bioprosthetic,
447–448
Heart valves, 440, 720–721
artificial, 38–40, 799–800
substitute, 472–476
HeartMate, 497–498
Hemoglobin; See also Polyhemoglobin
Hemoglobin, miscellaneous types of
soluble modified, 508–509
Hemoglobin, modified, 507–511
miscellaneous types of soluble
modified hemoglobin, 508–509
mw (molecular weight) distribution,
509
polyhemoglobin, 507–508
second-generation hemoglobin blood
substitutes, 510–511
third-generation blood substitutes, 511
in vitro biocompatibility screening test,
509–510
Hemoperfusion, 518
Heparin, ionically bound, 462–465
Heparin, thrombin inhibition without,
465
Heparinization, 462
Hierarchies, testing, 390–392
High-molecular-weight kininogen
(HMWK), 336
Hip arthroplasty, history of total,
529–532
femoral head prostheses, 531
long-stem prostheses, 531
mold arthroplasty, 529–531
short-stem prostheses, 531
total hip replacement arthroplasty,
531–532
Hip dislocation, total, 37
Hip replacement arthroplasty, total,
531–532
HMWK (high-molecular-weight
kininogen), 336
Host reactions to biomaterials,
293–354
biofilms, biomaterials and
device-related infections, 345–353
blood coagulation and blood-materials
interactions, 332–338
complement system, 318–328
immune response to foreign materials,
304–318
infection, 295–296
inflammation and wound healing,
296–304
inflammatory reaction to biomaterials,
293–294
innate and adaptive immunity,
304–318
systemic and remote effects, 294–295
systemic toxicity and hypersensitivity,
328–332
thromboembolic complications, 295
tumorigenesis, 295
tumorigenesis and biomaterials,
338–345
Human and animal tumors, implants
with, 339–341
Human plasma/blood, 505–506
Hyaluronan, proteoglycans and, 265
Hybrid bicomponent fibers, 91–92
Hydrocolloid dressings, 608
Hydrogel contact lenses, soft, 584–586
Hydrogels, 100–107
applications, 104–106
classification and basic structure,
100–101
complexation, 105
complexing, 104
determination of structural
characteristics, 103
intelligent or smart, 103–104
pH-sensitive, 103, 105
preparation, 101–102
properties of important biomedical,
103
swelling behavior, 102–103
temperature sensitive, 104
temperature-sensitive, 105
Hydrolysis-preclinical and clinical
experience, 414–416
poly(alkyl cyanoacrylates), 416
polyamides, 415–416
poly(ester urethanes), 415
polyesters, 414–415
polymers containing hydrolyzable
pendant groups, 416840 INDEX
Hydrolytic biodegradation, 412–416
host-induced hydrolytic processes,
413–414
hydrolysis-preclinical and clinical
experience, 414–416
structures of hydrolyzable polymers,
412–413
Hydrolyzable pendant groups, polymers
containing, 416
Hydrophilic effect, 61–62
Hydrophobic effect, 60–61
Hypersensitivity
and immunotoxicity, 330
systemic toxicity and, 328–332
I
IABPs (intraaortic balloon pumps), 487
ICDs (implantable
cardioverter-defibrillators), 485
ICDs, pacemakers and, 479–481
Imaging
digital, 404–406
low-voltage, 408
molecular, 809
Immune response to foreign materials,
304–318
Immune responses, pathology associated
with, 311–317
pathogenesis of antibody-mediated
disease, 313–314
pathogenesis of cell-mediated disease,
314–317
Immunity
innate and adaptive, 304–318
recognition and effector pathways in
adaptive, 307–311
recognition and effector pathways in
innate, 306–309
types of adaptive, 309
Immunoisolation, 728–734
applications, 733
challenge of, 728–729
Immunoisolation, devices for, 729–733
cells, 732
matrices, 732
membranes, 731–732
Immunologic toxicity of medical devices,
327
Immunoreagents, solid phase, 695–696
Immunotoxicity, hypersensitivity and,
326
Implant and device failure, 760–765
biological testing of implants, 763
design, 762
packaging, shipping, and storage, 764
patient/user, 764
raw materials, fabrication, and
sterilization, 763–764
testing of materials/design
configurations, 762–763
Implant modalities, currently used,
559–566
Implant retrieval and evaluation,
771–780
approach to assessment of host,
774–776
components of implant retrieval and
evaluation, 773–774
goals, 772–773
implanting responses, 774–776
role of implant retrieval in device
development, 776–777
useful information learned from
implant retrieval, 777–780
Implant retrieval and evaluation in
research, 753
correlation, surfaces and biomaterials
science, 765–771
implant and device failure, 760–765
implant retrieval and evaluation,
771–780
sterilization of implants and devices,
754–760
Implant retrieval, role of, 775–776
Implant retrieval, useful information
learned from, 777–780
Implantable artificial heart, total, 489
Implantable cardioverter-defibrillators
(ICDs), 485
Implantation, dental, 555–572
clinical environment, 567–569
currently used implant modalities,
559–566
general aspects of packaging and
preparation, 570
history, 555–559
tissue interfaces, 566–567
trends in research and development,
569–570
Implantation, ion beam, 207–208
Implants
biological testing of, 757
breast, 441–442
cardiovascular, 771–772
chemical compositions of metals used
for, 823–824
classification of degradable medical,
121–123
corneal, 587–589
for glaucoma, 589–590
with human and animal tumors,
339–341
pyrolytic carbon for long-term
medical, 168–180
for retinal detachment surgery, 589
silicone breast, 801–802
Implants and devices, sterilization of,
754–760
challenges to biomedical specialists,
760
EO sterilization, 757–758
miscellaneous sterilization processes,
759–760
overview of sterilization methods, 756
radiation sterilization, 758–759
steam sterilization, 754–757
sterility as a concept, 754–755
sterilization process development and
validation, 755–756
Implants, intracorneal, 588
Implants, intraocular lens, 589
biomaterials for IOLs, 592–597
emerging functional variations of
IOLs, 592
future of IOLs, 599–600
introduction to cataracts, 591–592
introduction to intraocular lens
implants, 591–592
introduction to optics of eye, 591–592
IOLs with variations of optical
function, 597–599
successfulness of IOLs, 592
Implants, steps in fabrication of,
138–141
metal-containing ore to raw metal
product, 138–139
raw metal product to stock metal
shapes, 139
stock metal shapes to final metal
devices, 139–141
stock metal shapes to preliminary
metal devices, 139–141
Imprinted surfaces, molecularly,690–691
In situ gelling and in situ precipitating
delivery systems, 638
In situ polymerization, 739–740
In vitro assessment of tissue
compatibility, 356–360
assay methods, 357–359
background concepts, 356–357
clinical use, 359–360
historical overview, 356
new research directions, 360
In vitro biocompatibility screening test,
509–510
In vitro tests, 786–787
of BMIs, 370–371
In vivo
applications, 97–99
evaluation of devices, 376–377
long-term testing, 787
In vivo assessment of tissue
compatibility, 360–367
biomaterial and device perspectives in
in vivo testing, 361–362INDEX 841
perspectives on in vivo medical device
testing, 365–366
selection of animal models for in vivo
tests, 364–365
specific biological properties assessed
by in vivo tests, 362–364
in vivo tests according to intended use,
361
In vivo medical device testing,
perspectives on, 365–366
In vivo testing, short-term, 787
In vivo tests
of BMIs, 375–376
selection of animal models for,
364–365
specific biological properties assessed
by, 362–364
Induction, tissue, 737
Industrial support for research, 794–797
Inert crystalline ceramics, nearly,
158–159
Inert materials, 457–462
albumin coating and alkylation,
459–460
Infections, 295–296, 500–501
biofilms, biomaterials and
device-related, 345–351
Inflammation
acute, 298–299
chronic, 299–304
wound healing and foreign-body
response, 296–304
Inflammatory reaction to biomaterials,
293–294
Infrared spectroscopy (IRS), 50–51
Inhibition, steric, 695
Injection method, cell, 713
Injury, cells and cell, 246–260
apoptosis, 258–259
biosynthetic machinery, 253–254
causes of cell injury, 256–257
cell injury and regeneration, 255–256
cell specialization and differentiation,
255
cellular integrity and movement,
251–252
cytoskeleton, 251–252
energy generation, 254–255
Golgi apparatus, 253–254
lysosomes and proteasomes, 254
mitochondria, 254–255
necrosis, 258
normal cell housekeeping, 246–248
nucleus-central control, 252–253
pathogenesis of cell injury, 257
plasma membrane-protection,
248–251
responses to cell injury, 257–258
rough and smooth ER (endoplasmic
reticulum), 253–255
waste disposal, 254
Injury, tissue response to, 272–274
cell regenerative capacity, 273–274
extracellular matrix remodeling, 274
inflammation and repair, 272–273
Innate and adaptive immunity, 304–318
Innate immunity, recognition and
effector pathways in, 306–309
Inorganic glasses, 25–26
Interactions
blood coagulation and
blood-materials, 332–338
cell-biomaterial, 260–281
cell-matrix, 265
cell/tissue-biomaterials, 274–277
Interfaces, electrode-electrolyte, 650–651
Intergranular corrosion, 432
Interpolating functions, properties of,
36–37
Interpretation, three-dimensional, 280
Intraaortic balloon pumps (IABPs), 487
Intracorneal implants, 588
Intraocular lens implants, 589
biomaterials for IOLs, 592–597
emerging functional variations of
IOLs, 592
future of IOLs, 599–600
introduction to cataracts, 591–592
introduction to intraocular lens
implants, 591–592
introduction to optics of eye, 591–592
IOLs with variations of optical
function, 597–599
successfulness of IOLs, 592
Intraocular lenses, contamination of, 57
Intraocular lenses (IOLs), 592
Intrauterine contraceptive devices
(IUDs), 442
Intrauterine devices, 798–799
IOLs (intraocular lenses), 591–602
accommodative, 598–599
adjustable power, 599
biomaterials for, 592–597
emerging functional variations of, 592
future of, 605
monofocal toric, 597
multifocal, 597–598
phakic, 598
successfulness of, 592
with variations of optical function,
597–599
yellow-tinted blue blocking, 599
Ion beam implantation, 207–208
Ion etching, reactive plasma and, 219
Ionic bonding, 23
IRS (infrared spectroscopy), 50–51
ISO standard for biocompatibility
testing, 791–792
Isolation; See Immunoisolation
Isotropy, 28
IUDs (intrauterine contraceptive
devices), 442
J
Joint replacement, total, 193
K
Kidney assist, 514–518
Kinetics and nature of biomaterials
components, 328–329
Knits, 94–95
L
Lamina, macromechanics of, 187–188
Laminates, macromechanics of,
188–189
Large animal models
in cardiac research testing, 379–396
in vascular research testing, 379–396
LB (Langmuir-Blodgett) deposition,
208–209
Lectin pathway, 320
Legal aspects of biomaterials, 797–804
artificial heart valves, 799–800
Biomaterials Access Assurance Act,
803
defensive manufacturing and
marketing, 804
intrauterine devices, 798–799
liability of design engineers, 803
pacemakers, 800
pedicle screws, 800–801
preemption, 802
science in courtrooms, 802–803
silicone breast implants, 801–802
Lens implants, intraocular, 589
biomaterials for IOLs, 592–597
emerging functional variations of
IOLs, 592
future of IOLs, 605
introduction to cataracts, 591–592
introduction to intraocular lens
implants, 591–592
introduction to optics of eye, 591–592
IOLs with variations of optical
function, 597–599
successfulness of IOLs, 592
Lenses
contamination of intraocular, 57
flexible perfluoropolyether, 586
soft contact, 442
soft hydrogel contact, 584–586842 INDEX
Lenses, contact, 583–587
flexible perfluoropolyether lenses, 586
general properties, 583–584
rigid contact lenses, 586–587
soft hydrogel contact lenses, 584–586
Liability of design engineers, 803
LIGA (lithography, electroplating,
molding), 219
Ligand binding assays, materials for,
686–692
miscellaneous biosensor strategies,
691–692
molecularly imprinted surfaces,
690–691
particles, 686–690
self-assembled monolayers, 690
surface-enhanced spectroscopies, 691
Ligand immobilization on solid phases,
692–695
linker arms, 692–694
photolinking, 694–695
steric inhibition, 695
Light microscopy, 277–279, 397–398
Linker arms, 692–694
Liver, 710
Long-stem prostheses, 532
Long-term testing in vivo, 787
Lost tissue or organ function, replacing,
713–714
Low-voltage imaging, 408
Lower cervical spine, finite element
model for, 37–38
Lung substitutes and assist, 524
Lysosomes and proteasomes, 254
M
Macromechanics
of lamina, 187–188
of laminates, 188–189
Manufacturing, defensive, 804
Marketing, defensive manufacturing
and, 804
Materials
bioresorbable and bioerodible,
115–127
blood contacting, 495–498
bulk properties of, 23–32
dental, 809
immune response to foreign, 304–318
methods for modifying surfaces of,
203–213
organ rejection and response to
synthetic, 317–318
scaffold, 736–737
self-assembled, 806
water and biological response to,
63–64
Materials, classes used in medicine,
66–232
natural materials, 127–137
polymers, 66–78
Materials, degradation of, 411–453
degradation of polymers, 411–430
degradative effects on metals and
ceramics, 430–439
pathological calcification of
biomaterials, 439–451
Materials/design configurations, testing
of, 762–763
Materials, important properties of,
31–32
effect of fabrication on strength, 32
fatigue, 31
toughness, 32
Materials, inert, 457–462
albumin coating and alkylation,
459–460
Materials market, orthopedic, 527–529
Materials, mechanical properties of,
26–28
elastic behavior, 27
elastic constants, 28
isotropy, 28
shear, 27
stress and strain, 27
tension and compression, 27
Materials, methods for modifying
surfaces of
chemical reaction, 203
conversion coatings, 212
high-temperature and high-energy
plasma treatments, 206
ion beam implantation, 207–208
laser methods, 213
LB (Langmuir-Blodgett) deposition,
208–209
multilayer polyelectrolyte absorption,
210–211
nature of plasma environment, 206
parylene coatings, 212–213
production of plasma environments for
deposition, 206
radiation grafting and photografting,
203–205
RFGD plasma depositing gas
processes, 205–206
RFGD plasmas for immobilization of
molecules, 206
SAMs (self-assembled monolayers),
209–210
silanization, 206–207
SMAs (surface-modifying additives),
211–212
Materials, natural, 127–137
biological consequences of collagen,
132–134
chemical modification of collagen,
132–134
elastin, 136
GAG (proteoglycans and
glycosaminoglycans), 134–136
graft copolymers of collagen, 136
graft copolymers of
glycosaminoglycans, 136
physical modification of collagen,

كلمة سر فك الضغط : books-world.net
The Unzip Password : books-world.net
أتمنى أن تستفيدوا من محتوى الموضوع وأن ينال إعجابكم
رابط من موقع عالم الكتب لتنزيل كتاب Biomaterials Science - An Introduction to Materials in Medicine
رابط مباشر لتنزيل كتاب Biomaterials Science - An Introduction to Materials in Medicine